Trial Profile
The Effect of Atorvastatin on the NO-system in Patients With Type 2 Diabetes and Nephropathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Diabetic nephropathies
- Focus Pharmacodynamics
- Acronyms STAD
- 30 Jan 2012 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 30 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 30 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.